Skip to main content

Table 2 Haemoglobin values and ability score; simulation B

From: Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: Is it feasible?

 

24M

24W

48M

48W

138M

138W

M

W

P

Haemoglobin (g/dL) Mean

10.38

11.10

10.20

11.36

10.32

10.82

10.30

11.09

<001

   SD

1.23

1.57

1.15

1.91

1.33

1.62

1.24

1.70

 

   Delta Hb

0.82

1.01

0.70

1.33

0.85

0.98

0.79

1.11

 

Haemoglobin values <11 g/dL (%)

70.39

44.22

73.28

45.94

65.73

53.58

69.80

47.91

<0.001

   SD

26.57

23.48

25.50

20.92

27.92

21.17

26.66

21.85

 

Haemoglobin values >12 g/dL (%)

12.53

23.68

8.68

30.18

14.32

21.90

11.84

25.25

<0.01

   SD

17.38

24.36

14.65

20.73

20.58

19.10

17.54

21.39

 

Haemoglobin values >13 g/dL (%)

5.51

10.77

2.89

17.09

4.60

11.02

4.33

12.69

<0.01

   SD

11.89

16.80

7.74

18.64

9.74

13.41

9.79

16.28

 

Ability score

1.20

1.52

1.22

1.23

1.25

1.24

1.22

1.33

ns

   SD

0.33

0.70

0.23

0.57

0.31

0.34

0.29

0.54

 
  1. Mean haemoglobin with SD and delta Hb, value percentages outside the target (during the 32 weeks of the simulation) and ability score for the 6 modalities, comparing monthly to weekly administration (half-life of 24, 48 and 138 hours; monthly M and weekly W administration) (simulation B). N = 25
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us